Skip to main content

Acarbose Treatment in Insulin-Dependent (Type I) Diabetes Mellitus

  • Conference paper
Acarbose for the Treatment of Diabetes Mellitus

Abstract

We all know well that during the last 30 years not a single new medication has been discovered which would present a mode of action different from that the established medications for the therapy of diabetes mellitus. It is characteristic that postprandial hyperglycemia in type I diabetics is particularly difficult to compensated since the increase of blood glucose cannot by synchronized with the high levels of exogenously administered insulin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Raptis S, Dimitriadis G, Karaiskos K, Rosenthal J, Zoupas C, Moulopoulos S (1980) Effects of an α-glucosidase inhibitor of insulin requirements and catecholamine levels assessed by the artificial β-cell. Diabetes 29 (suppl 2): 41A

    Google Scholar 

  2. Raptis S, Dimitriadis G, Etzrodt H, Karaiskos K, Hadjidakis D, Rosenthal J, Zoupas C, Diamentopoulos E (1982) The effects of acarbose treatment on release of pancreatic and gastrointestinal hormones in man. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 210–215

    Google Scholar 

  3. Dimitriadis G, Karaiskos K, Raptis S (1986) Effects of prolonged (6 months) α-glucosidase inhibition on blood glucose control and insulin requirements in patients with insulin-dependent diabetes mellitus. Horm Metab Res 18:253–255

    Article  PubMed  CAS  Google Scholar 

  4. Beyer J, Schulz G, Jäger H, Krause U, Cordes U (1981) Improvement of carbohydrate tolerance in insulin-dependent diabetics after administration of an α-glucosidase inhibitor demonstrated by artificial pancreas. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 451–454

    Google Scholar 

  5. Petzoldt R, Vrahimis J, Fink HD, Sauer H (1981) Effect of a single dose of acarbose on postprandial blood glucose values in insulin-dependent diabetics. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 427–432

    Google Scholar 

  6. Katsimantis D, Hillebrand I, Vikeli D, Lambropoulou V, Papachristou C (1981) Acarbose treatment in hospitalized diabetics. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 340–343

    Google Scholar 

  7. Aubell R, Boehme K, Berchtold P (1983) Blood glucose concentrations and glycosuria during and after one year of acarbose treatment. Arzneimittelforschung 33 (II), 9:1314–1318

    PubMed  CAS  Google Scholar 

  8. Schumann F, Janssen K, Aubell R, Christi HL (1981) Acarbose in diabetic out-patient treatment: results of a 3-month study. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 367–372

    Google Scholar 

  9. Willms B, Sachse G (1981) Short-term effects of acarbose in insulin-treated diabetics. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 471–473

    Google Scholar 

  10. Hillebrand I, Reis HE, Boehme K, Jahnke K (1981) The effect of the α-glucosidase acarbose on the urinary glucose excretion in poorly controlled insulin-dependent diabetics. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 482–485

    Google Scholar 

  11. Edmonds ME, Doddridge M, John PN, White JM, Watkins PJ (1981) Acarbose and postprandial glycaemia in the home blood-glucose profile. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 402–405

    Google Scholar 

  12. Henrichs IA, Heinze E, Kohne E, Teller WM (1981) Improved management of juvenile diabetes by acarbose. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 490–493

    Google Scholar 

  13. Dimitriadis G, Tessari P, Go V, Gerich J (1985) α-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus. Metabolism 34:261–265

    Article  PubMed  CAS  Google Scholar 

  14. Dimitriadis G, Tessari P, Go V, Gerich J (1982) Effects of disaccharidase inhibitor acarbose on meal and intravenous glucose tolerance in normal man. Metabolism 31:841–843

    Article  PubMed  CAS  Google Scholar 

  15. Puls W, Keup U, Krause H, Thomas G, Hoffmeister F (1982) The concept of glucosidase inhibition and its pharmacological realization. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 210–215

    Google Scholar 

  16. Caspary W, Lembcke W, Creutzfeldt W (1982) Inhibition of human intestinal α-glucosidase activity by acarbose and clinical consequences. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 27–37

    Google Scholar 

  17. Jenkins D (1982) Lente carbohydrate: a never approach to the dietary management of diabetes. Diabetes Care 5:634–641

    Article  PubMed  CAS  Google Scholar 

  18. Jenkins D, Ghafari H, Wolever T, Taxlor R, Jenkins A, Barker H, Fielden H, Bowling A (1982) Relationship between rate of digestion of foods and postprandial glycaemia. Diabetologia 22:450–455

    Article  PubMed  CAS  Google Scholar 

  19. Dimitriadis G, Gerich J (1983) Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 6:374–377

    Article  PubMed  CAS  Google Scholar 

  20. Pfeiffer EF, Thum C, Clemens AH (1974) The artificial beta-cell. A continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res 6:339–342

    Article  PubMed  CAS  Google Scholar 

  21. Jenkins D, Taylor R, Goff D, Fielden H, Misiewicz J, Sarson D, Bloom S, Alberti K (1981) Scope and specificity of acarbose in slowing carbohydrate absorption in man. Diabetes 30:951–954

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Raptis, S., Dimitriadis, G., Hadjidakis, D. (1988). Acarbose Treatment in Insulin-Dependent (Type I) Diabetes Mellitus. In: Creutzfeldt, W. (eds) Acarbose for the Treatment of Diabetes Mellitus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73583-7_48

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73583-7_48

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-19145-2

  • Online ISBN: 978-3-642-73583-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics